Home > Our Work > Metabolic & Mental Health > Foundational Trials

FOUNDATIONAL TRIALS

Baszucki Group funds translational and clinical research that seeks to investigate the use of metabolic therapies for serious mental illness as well as predictive biomarkers and mechanisms of action.

First European Trial Shows Promise of Keto as a New Treatment for Bipolar

The study is the first to use neuroimaging to demonstrate that a ketogenic diet may improve brain metabolism in individuals with a bipolar disorder diagnosis. Increased ketone levels were correlated with participants’ improvements in mood, energy, impulsivity, and anxiety, with some describing the intervention as life-changing.

 

Read more